Managers / Q1 2020 · view latest →
ROMAN BUTLER FULLERTON & CO
CIK 0000733444 · 680 CRAIG ROAD, STE 201, ST LOUIS, MO, 63141 · 314-997-1652
Reported Value
$113M
Q1 2020
Positions
133
Filings on Record
30
2019–present window
Filed
Apr 13, 2020
original filing
Summary
Roman Butler Fullerton & Co reported $113M in U.S.-listed holdings across 133 positions for Q1 2020.
Its largest position, MSFT, represents 4.3% of the portfolio.
Compared with Q4 2019, the fund opened 11 new positions and exited 39.
Portfolio Metrics
Turnover
+7.2%
vs prior filed quarter
Top-10 Concentration
+28.9%
share of reported value
Largest Position
+4.3%
Microsoft
New / Exited
11 / 39
positions this quarter
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 66.8% · $76M
- ETP · 22.8% · $26M
- Closed-End Fund · 4.3% · $5M
- REIT · 2.4% · $3M
- Other · 2.1% · $2M
- Other · 1.7% · $2M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| NFLXNETFLIX INC | NEW | +2.9K | 2.9K | +$1M | $1M |
| BMRNBIOMARIN PHARMACEUTICAL INC | NEW | +8.4K | 8.4K | +$708,000 | $708,000 |
| REGNREGENERON PHARMACEUTICALS | NEW | +1.1K | 1.1K | +$529,000 | $529,000 |
| BABAALIBABA GROUP HLDG LTD | NEW | +2.5K | 2.5K | +$477,000 | $477,000 |
| ASML HOLDING N V | NEW | +1.3K | 1.3K | +$352,000 | $352,000 |
| GLOBANT S A | NEW | +3.0K | 3.0K | +$262,000 | $262,000 |
| TJXTJX COS INC NEW | NEW | +4.8K | 4.8K | +$229,000 | $229,000 |
| AMDADVANCED MICRO DEVICES INC | NEW | +5.0K | 5.0K | +$227,000 | $227,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2020
45 positions
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | ISHARES TR | S&P US PFD STK · RUS 1000 GRW ETF · CORE S&P500 ETF · MIN VOL USA ETF · MODERT ALLOC ETF | 9.42% | $11M | 187.7K |
| 2 | MSFTMICROSOFT CORPhistory → | COM | 4.34% | $5M | 31.2K |
| 3 | MAMASTERCARD INCORPORATEDhistory → | CL A | 3.30% | $4M | 15.5K |
| 4 | AMZNAMAZON COM INChistory → | COM | 2.98% | $3M | 1.7K |
| 5 | AAPLAPPLE INChistory → | COM | 2.93% | $3M | 13.1K |
| 6 | PGPROCTER AND GAMBLE COhistory → | COM | 2.77% | $3M | 28.5K |
| 7 | TAT&T INChistory → | COM | 2.24% | $3M | 87.1K |
| 8 | BRK/BBERKSHIRE HATHAWAY INC DELhistory → | CL B NEW | 2.23% | $3M | 13.8K |
| 9 | ADBEADOBE INChistory → | COM | 1.82% | $2M | 6.5K |
| 10 | GOOGLALPHABET INC | CAP STK CL A · CAP STK CL C | 1.82% | $2M | 1.8K |
| 11 | VANGUARD GROUP | DIV APP ETF | 1.66% | $2M | 18.2K |
| 12 | PFEPFIZER INChistory → | COM | 1.61% | $2M | 56.0K |
| 13 | EOIEATON VANCE ENHANCED EQ INChistory → | COM | 1.51% | $2M | 141.5K |
| 14 | CICIGNA CORP NEWhistory → | COM | 1.48% | $2M | 9.5K |
| 15 | FIDELITY | CONSMR STAPLES | 1.33% | $2M | 46.5K |
| 16 | HDHOME DEPOT INChistory → | COM | 1.32% | $2M | 8.0K |
| 17 | DISDISNEY WALT COhistory → | COM DISNEY | 1.32% | $1M | 15.4K |
| 18 | NVDANVIDIA CORPhistory → | COM | 1.28% | $1M | 5.5K |
| 19 | JNJJOHNSON & JOHNSONhistory → | COM | 1.27% | $1M | 11.0K |
| 20 | METAFACEBOOK INChistory → | CL A | 1.26% | $1M | 8.5K |
| 21 | WMTWALMART INChistory → | COM | 1.25% | $1M | 12.5K |
| 22 | BACVERIZON COMMUNICATIONS INChistory → | COM | 1.23% | $1M | 25.9K |
| 23 | PROSHARES TR | S&P 500 DV ARIST | 1.21% | $1M | 23.8K |
| 24 | FQIDIGITAL RLTY TR INChistory → | COM | 1.08% | $1M | 8.8K |
| 25 | NDQINVESCO QQQ TR | UNIT SER 1 | 0.97% | $1M | 5.8K |
| 26 | NFLXNETFLIX INC | COM | 0.96% | $1M | 2.9K |
| 27 | AEEAMEREN CORP | COM | 0.94% | $1M | 14.7K |
| 28 | VRTXVERTEX PHARMACEUTICALS INC | COM | 0.90% | $1M | 4.3K |
| 29 | BMYBRISTOL MYERS SQUIBB CO | COM | 0.89% | $1M | 18.1K |
| 30 | EATON VANCE TXMGD GL BUYWR O | COM | 0.88% | $994,000 | 133.3K |
| 31 | CVSCVS HEALTH CORP | COM | 0.87% | $989,000 | 16.7K |
| 32 | VUGVANGUARD INDEX FDS | GROWTH ETF | 0.86% | $973,000 | 6.2K |
| 33 | ABTABBOTT LABS | COM | 0.85% | $966,000 | 12.2K |
| 34 | INTCINTEL CORP | COM | 0.83% | $946,000 | 17.5K |
| 35 | NOWSERVICENOW INC | COM | 0.82% | $924,000 | 3.2K |
| 36 | NDAQNASDAQ INC | COM | 0.80% | $912,000 | 9.6K |
| 37 | INVESCO EXCHNG TRADED FD TR | VAR RATE PFD | 0.80% | $906,000 | 42.2K |
| 38 | DGDOLLAR GEN CORP NEW | COM | 0.79% | $899,000 | 6.0K |
| 39 | INVESCO EXCHANGE TRADED FD T | BUYBACK ACHIEV | 0.79% | $892,000 | 18.4K |
| 40 | AMGNAMGEN INC | COM | 0.78% | $881,000 | 4.3K |
| 41 | ORCLORACLE CORP | COM | 0.76% | $866,000 | 17.9K |
| 42 | CRMSALESFORCE COM INC | COM | 0.76% | $863,000 | 6.0K |
| 43 | PEPPEPSICO INC | COM | 0.76% | $861,000 | 7.2K |
| 44 | SELECT SECTOR SPDR TR | SBI HEALTHCARE | 0.74% | $833,000 | 9.4K |
| 45 | WBAWALGREENS BOOTS ALLIANCE INC | COM | 0.72% | $819,000 | 17.9K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $364M | 267 | Apr 30, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $381M | 264 | Jan 26, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $373M | 256 | Nov 6, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $339M | 242 | Jul 30, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $258M | 221 | Apr 21, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $315M | 229 | Jan 30, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $332M | 249 | Oct 29, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $309M | 226 | Jul 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $267M | 211 | Apr 29, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $257M | 207 | Jan 31, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $212M | 181 | Oct 18, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $218M | 187 | Jul 25, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $201M | 189 | Apr 27, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $193M | 190 | Jan 23, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $157M | 169 | Oct 17, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $180M | 175 | Jul 26, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $216M | 193 | May 5, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $226M | 178 | Jan 24, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $214M | 185 | Nov 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $205M | 183 | Jul 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $200M | 193 | Apr 22, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $169M | 170 | Feb 1, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $153M | 153 | Oct 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $140M | 148 | Jul 28, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $113M | 133 | Apr 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $152M | 161 | Jan 27, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $145M | 162 | Oct 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $149M | 172 | Jul 22, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $143M | 173 | Apr 24, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $118M | 159 | Feb 4, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.